164 related articles for article (PubMed ID: 33581257)
1. Buxuhuayu decoction accelerates angiogenesis by activating the PI3K-Akt-eNOS signalling pathway in a streptozotocin-induced diabetic ulcer rat model.
Qu K; Cha H; Ru Y; Que H; Xing M
J Ethnopharmacol; 2021 Jun; 273():113824. PubMed ID: 33581257
[TBL] [Abstract][Full Text] [Related]
2. Bioactive triterpenoid compounds of Poria cocos (Schw.) Wolf in the treatment of diabetic ulcers via regulating the PI3K-AKT signaling pathway.
Ding X; Li S; Huang H; Shen J; Ding Y; Chen T; Ma L; Liu J; Lai Y; Chen B; Wang Y; Tan Q
J Ethnopharmacol; 2024 May; 325():117812. PubMed ID: 38301984
[TBL] [Abstract][Full Text] [Related]
3. Buyang Huanwu Decoction promotes angiogenesis in myocardial infarction through suppression of PTEN and activation of the PI3K/Akt signalling pathway.
Han X; Zhang G; Chen G; Wu Y; Xu T; Xu H; Liu B; Zhou Y
J Ethnopharmacol; 2022 Apr; 287():114929. PubMed ID: 34952189
[TBL] [Abstract][Full Text] [Related]
4. The mechanism of Chebulae Fructus Immaturus promote diabetic wound healing based on network pharmacology and experimental verification.
Qiu F; Fan S; Diao Y; Liu J; Li B; Li K; Zhang W
J Ethnopharmacol; 2024 Mar; 322():117579. PubMed ID: 38104882
[TBL] [Abstract][Full Text] [Related]
5. Network pharmacology analysis combined with experimental validation to explore the therapeutic mechanism of Schisandra Chinensis Mixture on diabetic nephropathy.
Ma Y; Deng Y; Li N; Dong A; Li H; Chen S; Zhang S; Zhang M
J Ethnopharmacol; 2023 Feb; 302(Pt A):115768. PubMed ID: 36280016
[TBL] [Abstract][Full Text] [Related]
6. The mechanism of Epimedium in the treatment of coronary atherosclerotic heart disease based on network pharmacology, molecular docking, and in vitro studies.
Xin G; Yuedong Y; Xuemei S; Chenhan M; Meng Z; Chenbo Z; Ning G; Xindong W
Eur Rev Med Pharmacol Sci; 2022 Apr; 26(7):2478-2488. PubMed ID: 35442463
[TBL] [Abstract][Full Text] [Related]
7. Shixiang Plaster, a Traditional Chinese Medicine, Promotes Healing in a Rat Model of Diabetic Ulcer Through the receptor for Advanced Glycation End Products (RAGE)/Nuclear Factor kappa B (NF-κB) and Vascular Endothelial Growth Factor (VEGF)/Vascular Cell Adhesion Molecule-1 (VCAM-1)/Endothelial Nitric Oxide Synthase (eNOS) Signaling Pathways.
Fei J; Ling YM; Zeng MJ; Zhang KW
Med Sci Monit; 2019 Dec; 25():9446-9457. PubMed ID: 31825949
[TBL] [Abstract][Full Text] [Related]
8. A network pharmacology approach and experimental validation to investigate the anticancer mechanism and potential active targets of ethanol extract of Wei-Tong-Xin against colorectal cancer through induction of apoptosis via PI3K/AKT signaling pathway.
Lin F; Zhang G; Yang X; Wang M; Wang R; Wan M; Wang J; Wu B; Yan T; Jia Y
J Ethnopharmacol; 2023 Mar; 303():115933. PubMed ID: 36403742
[TBL] [Abstract][Full Text] [Related]
9. Arnebin-1 promotes angiogenesis by inducing eNOS, VEGF and HIF-1α expression through the PI3K-dependent pathway.
Zeng Z; Huang WD; Gao Q; Su ML; Yang YF; Liu ZC; Zhu BH
Int J Mol Med; 2015 Sep; 36(3):685-97. PubMed ID: 26202335
[TBL] [Abstract][Full Text] [Related]
10. Angelica Dahurica ethanolic extract improves impaired wound healing by activating angiogenesis in diabetes.
Zhang XN; Ma ZJ; Wang Y; Sun B; Guo X; Pan CQ; Chen LM
PLoS One; 2017; 12(5):e0177862. PubMed ID: 28542422
[TBL] [Abstract][Full Text] [Related]
11. Integrated strategy of network pharmacology, molecular docking, HPLC-DAD and mice model for exploring active ingredients and pharmacological mechanisms of Penthorum chinense Pursh against alcoholic liver injury.
Jiang Y; Zhong M; Zhan H; Tao X; Zhang Y; Mao J; Geng Z; Gao B
J Ethnopharmacol; 2022 Nov; 298():115589. PubMed ID: 35926779
[TBL] [Abstract][Full Text] [Related]
12. Network pharmacology-based approach uncovers the pharmacodynamic components and mechanism of Fructus Tribuli for improving endothelial dysfunction in hypertension.
Wang SY; Sun XC; Lv XY; Li JN; Han B; Liu KL; Wang S; Sheng HG; Zhang C; Guo F; Cui YD
J Ethnopharmacol; 2023 Nov; 316():116749. PubMed ID: 37295575
[TBL] [Abstract][Full Text] [Related]
13. Mechanistic exploration and experimental validation of the Xiaochaihu decoction for the treatment of breast cancer by network pharmacology.
Liu Q; Luo Z; Sun M; Li W; Liu S
Aging (Albany NY); 2024 May; 16(9):7979-7999. PubMed ID: 38742934
[TBL] [Abstract][Full Text] [Related]
14. Network pharmacology-based prediction and validation of the active ingredients and potential mechanisms of the Huangxiong formula for treating ischemic stroke.
Zhao S; Zhang P; Yan Y; Xu W; Li J; Wang L; Wang N; Huang Y
J Ethnopharmacol; 2023 Aug; 312():116507. PubMed ID: 37080367
[TBL] [Abstract][Full Text] [Related]
15. Potential Molecular Mechanisms of Ephedra Herb in the Treatment of Nephrotic Syndrome Based on Network Pharmacology and Molecular Docking.
Yao T; Wang Q; Han S; Lu Y; Xu Y; Wang Y
Biomed Res Int; 2022; 2022():9214589. PubMed ID: 35837376
[TBL] [Abstract][Full Text] [Related]
16. Uncovering the pharmacological mechanism of Wei-Tong-Xin against gastric ulcer based on network pharmacology combined with in vivo experiment validation.
Liu W; Zhang X; Ma T; Wang J; Lv X; Wu B; Yan T; Jia Y
J Ethnopharmacol; 2022 Jul; 293():115282. PubMed ID: 35405254
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanism of Fufang Zhenzhu Tiaozhi capsule in the treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease based on network pharmacology and validation in minipigs.
Wang H; Tan H; Zhan W; Song L; Zhang D; Chen X; Lin Z; Wang W; Yang Y; Wang L; Bei W; Guo J
J Ethnopharmacol; 2021 Jun; 274():114056. PubMed ID: 33771638
[TBL] [Abstract][Full Text] [Related]
18. Zhisou powder displays therapeutic effect on chronic bronchitis through inhibiting PI3K/Akt/HIF-1α/VEGFA signaling pathway and reprograming metabolic pathway of arachidonic acid.
Dong Y; Liu Y; Tang J; Du J; Zhuang X; Tan S; Yang Y; Yin D
J Ethnopharmacol; 2024 Jan; 319(Pt 1):117110. PubMed ID: 37673198
[TBL] [Abstract][Full Text] [Related]
19. Tongmai Yangxin pill reduces myocardial no-reflow by regulating apoptosis and activating PI3K/Akt/eNOS pathway.
Chen R; Chen T; Wang T; Dai X; Meng K; Zhang S; Jiang D; Wang Y; Zhou K; Geng T; Xu J; Wang Y
J Ethnopharmacol; 2020 Oct; 261():113069. PubMed ID: 32619593
[TBL] [Abstract][Full Text] [Related]
20. Fufang Shenhua tablet inhibits renal fibrosis by inhibiting PI3K/AKT.
Li R; Shi C; Wei C; Wang C; Du H; Liu R; Wang X; Hong Q; Chen X
Phytomedicine; 2023 Jul; 116():154873. PubMed ID: 37257328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
